RUBI:NASDAQRubico Inc. Analysis
Data as of 2026-06-24 - not real-time
$0.39
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Rubico Inc. is trading at an ultra‑low price of $0.391 after a 1‑for‑25 reverse stock split, with the stock hovering just above its calculated support of $0.358 and well below the resistance level of $1.24. The Relative Strength Index sits at 22, indicating the stock is deeply oversold, while the MACD histogram is positive (+0.148) suggesting a nascent bullish momentum despite an overall bearish trend. Volatility is extreme at over 226% (30‑day) and beta is modest at 0.65, reflecting a highly erratic price path that can swing sharply on news. Recent news of the reverse split triggered a sharp after‑hours decline of more than 14%, underscoring market uncertainty and liquidity pressure.
Fundamentally, the company reports a negligible trailing P/E of 0.0008 versus an industry average of 30.94, and a price‑to‑book ratio of 0.00033 against a book value per share of $1,187.99. However, the balance sheet is distressed with total debt of $82.28 M and a debt‑to‑equity ratio of 179.7, while revenue is contracting (-5.1%). The DCF model implies a fair value near $13.28, highlighting a massive valuation gap but also signalling the need for a turnaround. With a market cap of only $1.28 M and an average daily volume that dwarfs the float, liquidity is a serious concern. Overall, the stock appears severely undervalued on paper but is hampered by high leverage, extreme volatility, and uncertain near‑term catalysts.
Fundamentally, the company reports a negligible trailing P/E of 0.0008 versus an industry average of 30.94, and a price‑to‑book ratio of 0.00033 against a book value per share of $1,187.99. However, the balance sheet is distressed with total debt of $82.28 M and a debt‑to‑equity ratio of 179.7, while revenue is contracting (-5.1%). The DCF model implies a fair value near $13.28, highlighting a massive valuation gap but also signalling the need for a turnaround. With a market cap of only $1.28 M and an average daily volume that dwarfs the float, liquidity is a serious concern. Overall, the stock appears severely undervalued on paper but is hampered by high leverage, extreme volatility, and uncertain near‑term catalysts.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Reverse split-induced price volatility
- Bearish trend despite oversold technicals
- Thin market liquidity
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Massive debt burden limiting operational flexibility
- Potential upside if restructuring succeeds
- Continued high volatility and uncertain earnings
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF fair value suggests large upside
- Value‑oriented pricing relative to book and earnings
- Possible industry recovery in marine shipping
Key Metrics & Analysis
Financial Health
Revenue Growth-5.10%
Profit Margin11.24%
P/E Ratio0.0
ROE6.62%
ROA6.26%
Debt/Equity179.66
P/B Ratio0.0
Op. Cash Flow$11.3M
Free Cash Flow$9.3M
Industry P/E30.9
Technical Analysis
TrendBearish
RSI22.5
Support$0.36
Resistance$1.24
MA 20$0.53
MA 50$1.89
MA 200$1,080.09
MACDBullish
VolumeIncreasing
Fear & Greed Index87.71
Valuation
Fair Value$13.28
GradeUndervalued
TypeValue
Risk Assessment
Beta0.65
Volatility226.17%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.